Clinical Trials: Retinitis Pigmentosa

San Francisco : University of California, San Francisco

Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa

Chicago : The Chicago Lighthouse (University of Illinois at Chicago, Pangere Center for Inherited Retinal Disease)

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)

Baltimore : Wilmer Eye Institute (Johns Hopkins University)

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)

West Orange : Kessler Institute for Rehabilitation Updated

Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury

Portland : Casey Eye Institute

Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B

Montreal : Montreal Children's Hospital, McGill University Health Centre

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)

Aachen : RWTH University Eye Clinic

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

Dresden : Helmut Sachs, MD, PD

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Frankfurt-Hoechst : Claus Eckardt, MD, Prof.

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Karlsruhe : Augenklinik des Staedtischen Klinikums

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

Kiel : Johann Roider, MD, Prof.

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

View More »

Koln : Center for Ophthalmology - University of Koln

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

Munich : Klinikum rechts der Isar - Technical University

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

Tubingen : Institute for Ophthalmic Research, University of Tubingen

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)

Tuebingen : Karl-Ulrich Bartz-Schmidt, MD, Prof.

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Hong Kong : Ophthalmology Eye Institute, University of Hong Kong

Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Budapest : Miklos Resch, MD, PhD

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Pisa : University of Pisa Eye Surgery Department

Argus® II Retinal Prosthesis System Post-Market Surveillance Study

Pisa : Stanislao Rizzo, MD

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Rotterdam : The Rotterdam Eye Hospital

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)

Zurich : University Hospital Balgrist- Uniklinik Balgrist, Forschstrasse 340

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury

London : Moorefield Eye Hospital

Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)

London : Timothy L Jackson, MB.ChB, PhD, FRCOphth

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients

Oxford : Robert MacLaren, MD, Prof., DPhil DipEd FRCOphth FRCS

Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients